Why Medical Geneticists & Genetic Counselors Get Sued: The Misread Variant and the Counseling That Never Happened

By John Mahoney · June 2026 · 8 min read

Medical genetics is one of the rarest specialties to sue and one of the most consequential when a claim lands, because the harm is almost never a transient injury — it is a child born with a condition that could have been detected or avoided, and the damages run for a lifetime. Most of the field's exposure does not look like a surgical error or a medication mistake. It looks like a test result that was misread, a screening that was never offered, an abnormal finding that was never followed up, or a counseling conversation that never happened. An attorney who screens these cases like a typical missed-diagnosis file will misjudge both the merit gate and the damages ceiling. This guide explains where medical-genetics liability actually lives, the cannot-miss failures behind it, and what separates a strong case from a weak one — for plaintiff and defense med-mal attorneys.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Wrongful-birth and wrongful-life theories, the duty to recontact, and the admissibility of genetic-counseling testimony vary sharply by jurisdiction and are still evolving; treat the discussion below as directional, verify against the controlling state law, and value any individual case on its own record.

The Frequency-and-Severity Reality

By frequency, medical genetics is among the lowest-volume specialties in malpractice. There are comparatively few clinical geneticists and certified genetic counselors, the patient encounters per provider are limited, and many claims that involve a genetic test never name the geneticist or counselor — they name the ordering obstetrician, the laboratory, or the hospital. As a result, closed-claims datasets report genetics-specific claims only rarely, and the named-defendant analysis often runs through adjacent specialties. The annual exposure for an individual clinical geneticist is low; the field is not where high-frequency litigation lives.

Severity, by contrast, is at the top of the spectrum. When a medical-genetics claim is paid, it is frequently because a child was born with a serious, lifelong condition — and the damages model is built on decades of medical care, special education, attendant services, lost earning capacity, and life-care planning. These are among the highest-value damages calculations in all of medical malpractice, on par with severe birth-injury and neurological-catastrophe cases. The defining feature of the specialty is this gap: claims are uncommon, but the ones that succeed are catastrophic in value. The screening lesson is that a single missed step — an un-offered carrier screen, a misread variant, a counseling session that didn't disclose a known risk — can anchor a lifetime-care damages model, so the merit and causation analysis deserves far more rigor than the low claim frequency would suggest.

The Dominant Allegation Types

Medical-genetics claims cluster around the interpretation, ordering, and communication of genetic information, plus a consent-and-privacy thread that runs through all of it:

• Misinterpretation or mislabeling of a genetic test result — the core allegation: a pathogenic variant called benign, a positive result reported as negative, false reassurance from a normal screen, or a sample/patient mix-up. This is the misread-variant claim.
• Failure to offer or order indicated testing or screening — carrier screening, prenatal cell-free DNA (cfDNA / NIPT), diagnostic amniocentesis or CVS, or newborn screening that the standard of care indicated and that was never offered or ordered.
• Failure to follow up an abnormal or actionable result — a positive screen, a flagged newborn-screening result, or a variant that returned but was never communicated or acted on — a closed-loop failure.
• Inadequate genetic counseling — the conversation that supports wrongful-birth and wrongful-life theories: a known reproductive risk, recurrence risk, or testing option that was never explained, depriving the parents of an informed reproductive choice.
• Variant-of-uncertain-significance (VUS) reclassification and the duty to recontact — a variant later reclassified as pathogenic where the question becomes whether the provider had a duty to recontact the patient with the updated interpretation.
• Consent, privacy, and disclosure — informed consent for testing, GINA and genetic-privacy obligations, and the handling of incidental or secondary findings.

The structural point: medical genetics is an information specialty, not a procedural one. The injury is almost always the loss of an informed choice or the loss of a timely intervention, and the merit analysis turns on whether the right test was offered, read correctly, communicated, and acted on — in that order.

The Cannot-Miss Conditions and Failures

The conditions and failures that drive medical-genetics litigation are:

• The misread or mislabeled variant. A pathogenic variant interpreted as benign or a VUS, a positive result reported as negative, or a specimen mix-up that produces false reassurance. This is the highest-stakes diagnostic failure in the field and the most direct path to a wrongful-birth claim.
• Carrier screening never offered. Failure to offer or order indicated carrier screening — for conditions such as cystic fibrosis, spinal muscular atrophy, fragile X, or ancestry-based panels — where the standard of care and the family or ancestral history called for it.
• Prenatal screening and diagnosis gaps. Failure to offer cfDNA / NIPT or diagnostic testing, misinterpretation of a screening result, or failure to convey that a screen is not diagnostic and that confirmatory testing was available.
• Newborn-screening failures. A flagged newborn-screening result that was not communicated or followed up, delaying treatment of a metabolic or genetic condition where early intervention changes the outcome.
• Family-history and consanguinity risk-assessment failures. An inadequate pedigree, a missed consanguinity flag, or a known familial condition that should have triggered targeted testing and counseling but did not.
• The recontact failure. A VUS later reclassified as pathogenic, or new testing options that became standard, where the patient was never recontacted with information that would have changed a reproductive or surveillance decision.

For these cases, the single most actionable screening question is the closed-loop-plus-counseling question: was the indicated test offered and ordered, was the result interpreted correctly, was it communicated to the patient, and was the patient counseled about what it meant for their reproductive or treatment choices? A medical-genetics claim very often turns on one broken link in that chain — and on whether the chart documents the counseling conversation at all, because in this specialty the conversation is the standard of care.

The Contributing Factors That Drive Payouts

Across medical-genetics claims, the recurring contributing factors are:

• Interpretation and clinical judgment — the costliest factor: a variant classified incorrectly, a screen read as reassuring when it was not, or a result whose clinical significance was understated. The misread variant is the high-severity driver because it directly enables the wrongful-birth theory.
• Failure to offer or order indicated testing — an omission rather than an error of commission, but in genetics the omission is the negligence: the standard of care is increasingly defined by professional-society guidelines on who should be offered which screen, and an un-offered indicated test is a documented gap.
• Communication and counseling — the failure to convey a risk, a recurrence probability, or the limits of a screening test. Because the harm is the loss of an informed reproductive choice, a thin or absent counseling record is often the difference between a defensible file and a paid claim.
• Result-notification and follow-up — an abnormal result, a flagged newborn screen, or a reclassified variant that was generated but never reached the patient or the ordering clinician — a closed-loop failure that also weighs heavily in adjacent-specialty claims.
• Consent, privacy, and incidental findings — inadequate informed consent for testing, GINA and genetic-privacy missteps, and the mishandling or non-disclosure of secondary findings, which add distinct theories on top of the diagnostic core.
• Documentation — incomplete pedigrees, undocumented counseling sessions, and missing records of what was offered, declined, or explained, which consistently decide whether a claim is paid.

Two of these are genetics-specific levers. The first is the counseling record: because the injury is the loss of an informed choice, the chart's documentation of what the patient was told — the risks, the options, the limits of the test — frequently decides the case more than any laboratory error. The second is the duty to recontact: a VUS reclassification or a newly available test raises an evolving and jurisdiction-dependent question about whether the provider had an ongoing obligation to reach back out, and that question can reopen a file years after the original encounter.

Strong Case vs. Weak Case in Medical Genetics Malpractice

The same factors grade the file, and the framing is useful to both sides.

What makes a medical-genetics case strong (plaintiff) / dangerous (defense)

• A clearly pathogenic variant that was reported as benign or negative, or a positive carrier or prenatal result that was never communicated — a clean misread or closed-loop failure with a child born affected.
• An indicated carrier or prenatal screen that the family or ancestral history plainly called for and that was never offered or ordered, supporting a wrongful-birth theory that the parents were deprived of an informed reproductive choice.
• A counseling record that is absent or generic where a specific, known reproductive or recurrence risk should have been disclosed, with credible testimony that the parents would have acted differently had they known.
• A VUS reclassified as pathogenic, or a flagged newborn screen, where the provider had the information and the means to recontact or follow up and did not, and earlier action carried a materially better outcome.

What makes a medical-genetics case weak (plaintiff) / defensible (defense)

• A correctly interpreted result, reported in line with the laboratory classification standards in effect at the time, with documented communication to the patient and the ordering clinician — the loop intact and the interpretation defensible.
• A documented counseling session in which the relevant risks, the screening-versus-diagnostic distinction, and the available options were explained, framing the outcome as a disclosed and accepted risk rather than negligence.
• A record showing the patient declined offered testing, declined recommended diagnostic confirmation, or did not return for follow-up, breaking the causation chain.
• A variant that was a genuine VUS under the consensus framework at the time, with no clear duty-to-recontact obligation in the controlling jurisdiction, and a causation theory that depends on hindsight reclassification.

Medical genetics rewards a disciplined chain analysis. The case lives or dies on four sequential links — was the right test offered, was it read correctly, was the result communicated, and was the patient counseled about what it meant — and on the causation question of whether the parents or patient would have made a different, available choice. Whichever side you are on, grading the file means walking that chain link by link, scrutinizing the counseling and recontact record, and pressure-testing the genetics and life-care experts who will carry the lifetime-damages model.

Bottom Line

Medical geneticists and genetic counselors get sued rarely, and many claims that touch genetic testing never name them at all. But the specialty hides the highest severity in medicine: when a claim succeeds, it is usually because a child was born with a lifelong condition that earlier or better information could have detected or avoided, and the damages run for a lifetime of care. The cannot-miss facts are the misread or mislabeled variant, the indicated test that was never offered, the abnormal result that was never followed up, the counseling conversation that never happened, and the reclassified variant that triggered no recontact. Whether you are screening these cases for the plaintiff or defending them, treat the file as an information chain — offered, interpreted, communicated, counseled — and grade it on the closed loop, the counseling record, and the documented choices, anchored to a lifetime-care damages model rather than the visible injury alone.

Questions? Contact us at [email protected] or (856) 979-6525

🔎 Screening a case in a different specialty? Browse all 70 specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →